Extended First Uninterrupted Sleep Period in Elderly Patients Following Treatment with AV002 - Benjamin Brucker

(Length of Presentation: 11 min)

Benjamin Brucker, MD presents his 2018 AUA presentation Extended First Uninterrupted Sleep Period in Elderly Patients Following Treatment with AV002, an Emulsified Low Dose Vasopressin Analog for Nocturia in a detailed video lecture. A brief review of the short-term and long-term negative consequences of nocturia highlights the relevance of this trial.  The objective of the study was to assess Noctiva (AV002), in older adults (≥65 years and ≥75 years) on first uninterrupted sleep period, the percentage of nights with < 1 nocturic voids, and safety.   They sought to evaluate if efficacy in this more difficult to treat population is consistent with the broader > 50 years population.


Biography:
Benjamin M. Brucker, MD